Early evaluation of tumour metabolic response using [(18)F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

Quantitation of metabolic changes in tumours may provide an objective measure of clinical and subclinical response to anticancer therapy. This pilot study assesses the value of quantitation of metabolic rate of glucose (MRGlu) measured in mmol min(−1)ml(−1)to assess early subclinical response to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Brock, C S, Young, H, O'Reilly, S M, Matthews, J, Osman, S, Evans, H, Newlands, E S, Price, P M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363328/
https://www.ncbi.nlm.nih.gov/pubmed/10682673
http://dx.doi.org/10.1054/bjoc.1999.0971

Ejemplares similares

Ejemplares similares